Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Other Accumulated Expenses (2018 - 2019)

Historic Other Accumulated Expenses for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q2 2019 value amounting to $280000.0.

  • X4 Pharmaceuticals' Other Accumulated Expenses fell 3665.16% to $280000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $280000.0, marking a year-over-year decrease of 3665.16%. This contributed to the annual value of $249000.0 for FY2018, which is N/A changed from last year.
  • Latest data reveals that X4 Pharmaceuticals reported Other Accumulated Expenses of $280000.0 as of Q2 2019, which was down 3665.16% from $271000.0 recorded in Q1 2019.
  • X4 Pharmaceuticals' Other Accumulated Expenses' 5-year high stood at $442000.0 during Q2 2018, with a 5-year trough of $249000.0 in Q4 2018.